Use of haloperidol as a trial of treatment in diagnosing major depressive disorder with subclinical psychotic features
No Thumbnail Available
Authors
Foo, Yu Cheng
Sultana, Yasmin
Check for full-text access
Issue Date
08/07/2025
Type
Journal article
Language
Keywords
Mental Health
Alternative Title
Abstract
Patients may present with subclinical psychotic features not meeting established diagnostic thresholds for psychosis. Here, we describe our experience of using Haloperidol as a trial of treatment to clarify the diagnostic uncertainty in a patient presenting with major depressive disorder with subclinical psychotic features. Our case highlights the importance of having a high index of suspicion for subclinical psychosis in patients presenting with treatment-resistant affective symptoms despite the use of multiple classes of antidepressant and/or anti-anxiety medications, as well as the need to undertake comprehensive assessments to clarify the differential diagnosis. Our experience may support trialling treatment with antipsychotics if a diagnosis of subclinical psychotic phenomena is being considered.
Description
Citation
BMJ Case Reports CP 2025;18:e265945.
Publisher
License
Journal
BMJ Case Reports
Volume
18
Issue
7